Sarah James
Stock Analyst at Cantor Fitzgerald
(1.96)
# 3,134
Out of 5,124 analysts
300
Total ratings
34.67%
Success rate
-7.42%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $14.19 | +19.80% | 18 | Dec 3, 2025 | |
| CNC Centene | Maintains: Neutral | $38 → $41 | $41.15 | -0.36% | 16 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Overweight | $78 → $95 | $79.36 | +19.71% | 16 | Oct 30, 2025 | |
| UHS Universal Health Services | Maintains: Neutral | $227 → $250 | $218.02 | +14.67% | 27 | Oct 29, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $245 | $198.72 | +23.29% | 23 | Oct 29, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $210 → $180 | $173.54 | +3.72% | 14 | Oct 24, 2025 | |
| SGRY Surgery Partners | Reiterates: Overweight | $36 | $15.45 | +133.01% | 13 | Oct 7, 2025 | |
| HCAT Health Catalyst | Reiterates: Neutral | $4 | $2.39 | +67.36% | 8 | Oct 7, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $444 | $466.86 | -4.90% | 21 | Oct 7, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $440 | $330.11 | +33.29% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $275.23 | +32.62% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $25.68 | +9.03% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $290 | $256.13 | +13.22% | 21 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $350.55 | +38.35% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $22.07 | +31.40% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $3.41 | +339.88% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $0.88 | +469.61% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $7.00 | +42.86% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $113.61 | +17.07% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $26.71 | +57.24% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $5.19 | -3.66% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $8.17 | -38.80% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $19.75 | +6.33% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $71.35 | -45.34% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $75.58 | +155.36% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.12 | - | 2 | Mar 1, 2017 |
Acadia Healthcare Company
Dec 3, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $14.19
Upside: +19.80%
Centene
Oct 30, 2025
Maintains: Neutral
Price Target: $38 → $41
Current: $41.15
Upside: -0.36%
CVS Health
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $79.36
Upside: +19.71%
Universal Health Services
Oct 29, 2025
Maintains: Neutral
Price Target: $227 → $250
Current: $218.02
Upside: +14.67%
Tenet Healthcare
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $198.72
Upside: +23.29%
Molina Healthcare
Oct 24, 2025
Maintains: Neutral
Price Target: $210 → $180
Current: $173.54
Upside: +3.72%
Surgery Partners
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $15.45
Upside: +133.01%
Health Catalyst
Oct 7, 2025
Reiterates: Neutral
Price Target: $4
Current: $2.39
Upside: +67.36%
HCA Healthcare
Oct 7, 2025
Reiterates: Overweight
Price Target: $444
Current: $466.86
Upside: -4.90%
UnitedHealth Group
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $330.11
Upside: +33.29%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $275.23
Upside: +32.62%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $25.68
Upside: +9.03%
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $256.13
Upside: +13.22%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $350.55
Upside: +38.35%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $22.07
Upside: +31.40%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $3.41
Upside: +339.88%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $0.88
Upside: +469.61%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $7.00
Upside: +42.86%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $113.61
Upside: +17.07%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $26.71
Upside: +57.24%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $5.19
Upside: -3.66%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $8.17
Upside: -38.80%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $19.75
Upside: +6.33%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $71.35
Upside: -45.34%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $75.58
Upside: +155.36%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.12
Upside: -